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Purpose: To investigate use of an improved ocular tear film analysis protocol (OPI 2.0) in the 
Controlled Adverse Environment (CAESM) model of dry eye disease, and to examine the utility 
of new metrics in the identification of subpopulations of dry eye patients.
Methods: Thirty-three dry eye subjects completed a single-center, single-visit, pilot CAE 
study. The primary endpoint was mean break-up area (MBA) as assessed by the OPI 2.0 system. 
Secondary endpoints included corneal fluorescein staining, tear film break-up time, and OPI 2.0 
system measurements. Subjects were also asked to rate their ocular discomfort throughout the 
CAE. Dry eye endpoints were measured at baseline, immediately following a 90-minute CAE 
exposure, and again 30 minutes after exposure.
Results: The post-CAE measurements of MBA showed a statistically significant decrease from 
the baseline measurements. The decrease was relatively specific to those patients with moderate 
to severe dry eye, as measured by baseline MBA. Secondary endpoints including palpebral fissure 
size, corneal staining, and redness, also showed significant changes when pre- and post-CAE 
measurements were compared. A correlation analysis identified specific associations between 
MBA, blink rate, and palpebral fissure size. Comparison of MBA responses allowed us to identify 
subpopulations of subjects who exhibited different compensatory mechanisms in response to 
CAE challenge. Of note, none of the measures of tear film break-up time showed statistically 
significant changes or correlations in pre-, versus post-CAE measures.
Conclusion: This pilot study confirms that the tear film metric MBA can detect changes in 
the ocular surface induced by a CAE, and that these changes are correlated with other, estab-
lished measures of dry eye disease. The observed decrease in MBA following CAE exposure 
demonstrates that compensatory mechanisms are initiated during the CAE exposure, and that 
this compensation may provide the means to identify and characterize clinically relevant sub-
populations of dry eye patients.
Keywords: tear film break-up time, mean break-up area, interblink interval, controlled adverse 
environment, ocular protection index
Introduction
Dry eye disease is a term used to describe a collection of disorders with a shared 
diagnosis of tear film dysfunction that lead to decreased visual acuity, ocular pain, 
burning, and the potential for corneal scarring.1 Prevalence is highest in older indi-
viduals and in women, as well those who have previously undergone laser vision 
correction.1,2 The most recent reports suggest that moderate to severe dry eye currently 
affects between 5 and 10 million Americans, with estimates of ten times that number 
worldwide.2 Current treatments include artificial tears, tear plugs, or immunosup-
pressive drugs such as cyclosporine, but these treatments are often ineffective for 
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many dry eye sufferers, and so, the unmet need for new 
therapeutics is significant.2
Understanding of the pathophysiology of dry eye has 
advanced considerably in recent years, and what was once 
thought to be a condition due simply to insufficient tear pro-
duction, is now recognized as a multifactorial collection of 
diseases.3 This is a result of significant strides in ocular surface 
biology research, and improvements in clinical assessment 
techniques such as, corneal staining, blink  pattern analysis, and 
various measures of tear film stability.4,5 In two recent papers 
we described the stepwise development of our improved method 
of tear film analysis, which we have designated the ocular tear 
film analysis protocol OPI 2.0 (Ora, Inc. Andover MA, USA; 
patent pending) system.6,7 This method combines a number of 
optimized parameters with automated video data capture and 
analysis, to generate a more objective, quantitative measure 
of tear film dynamics. These improvements have the poten-
tial to substantially enhance tear film metrics, and represent 
a key advance over previous methods of tear film analysis.
Tear film stability and blink behavior are  inexorably 
linked. The tear f ilm is established by the sweeping, 
 squeegee-like action of the lids, and the rate and pattern 
of blinks is in turn, modulated by feedback from corneal 
sensory nerves.3,8 Efforts to measure properties of the 
tear film led to the development of the tear film break-up 
time (TFBUT), a method of analysis in which subjects are 
asked to refrain from blinking while an observer monitors 
the integrity of the tear film.8 This “forced stare” approach 
allowed the first estimates of inherent tear film stability and 
provided the means for addressing the impact of different 
disorders, drug treatments, or environmental conditions, 
on the  physiochemical properties (and therefore, functional 
 attributes) of the tear film.1,4 The standard values developed 
for use with this method were .10 seconds for normal sub-
jects, and ,10 seconds for subjects with dry eye.1,4
More recently, studies have identified limitations to 
both the method used to measure TFBUT, as well as the 
metric itself. For example, it was found that reduction and 
standardization of the quantity of fluorescein used, led to a 
shift of the reference values for TFBUT (to a mean value 
of 7 seconds for normal subjects, and 2.5 seconds for those 
with dry eye).5 Similarly, our goal in developing the OPI 
2.0 system was to enhance and streamline dry eye metrics 
by measuring tear film stability under conditions of natural, 
rather than forced stare blinking.6,7 Furthermore, by capturing 
the natural dynamics of the tear film with automated methods, 
it is possible to expand upon previous studies of the interac-
tion between blinking and tear film behavior.8–13
Blinking is a reflex function regulated by the combination 
of autonomic inputs and sensory feedback about environ-
mental conditions.14 Blink rate is known to increase under 
adverse conditions such as those presented by the Controlled 
Adverse Environment (CAESM), a clinical model that repro-
duces a standard ocular challenge (by regulation of humidity, 
 temperature, airflow, lighting conditions, and visual tasking) 
for the investigation of treatments for dry eye.1,4,13,15,16 Our 
early assessments of both blink behavior and tear film stability 
led to our development of the Ocular Protection Index (OPI), 
a tool used in observational and clinical studies of dry eye, to 
evaluate the interaction between blinking and TFBUT.9,13–16 
We defined OPI as the ratio of interblink interval (IBI) and 
TFBUT; lower values of the index and particularly values 
less than one, were associated with increased risk of keratitis 
(since on average, break-up of the tear film and subsequent 
corneal exposure would occur prior to the next blink).9 Our 
more recent studies employed break-up and blink data cap-
tured with the OPI 2.0 system, to yield another estimate of 
corneal surface exposure.7 This alternative index relied upon 
the mean break-up area (MBA) rather than a break-up time 
elicited under forced stare conditions.6
The OPI 2.0 system was designed to evaluate ocular 
surface protection under a normal blink pattern and normal 
visual conditions, using fully automated software algorithms 
that provide real-time measurement of corneal exposure.7 
This system provides a simultaneous measurement of both 
break-up area and blink rate. Video capture allows calcula-
tion of a mean corneal surface exposure (we abbreviate this 
as mean break-up area, MBA) as well as additional metrics, 
such as palpebral fissure width. In an initial paper, we showed 
that video capture of MBA and blink rates was superior to the 
combination of forced stare TFBUT and IBI in  distinguishing 
normal subjects from those with signs and symptoms of dry 
eye.6 In a second paper, we demonstrated that our automated 
method provided accurate, reliable measures of corneal 
surface exposure, and again showed that these values could 
be used to distinguish between normal subjects and subjects 
with dry eye.7
In this study, we explored the ability of the OPI 2.0 system 
to identify the changes and modifications of the tear film 
after exposing dry eye subjects to the CAE. A key aspect 
of the CAE is its utility in distinguishing subpopulations 
of dry eye patients. Subjects challenged by environmental 
changes (such as those presented by the CAE) normally 
respond with some degree of physiological compensation, 
and previous studies have shown that the ability of these 
mechanisms to adequately compensate for environmental 
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challenges is reduced in those with dry eye.17 Therefore, the 
nature and extent of the compensatory response will likely 
be a reflection of the underlying tear film pathology. These 
compensatory mechanisms, such as changes in blink rate or 
reflex tearing, are likely to have an impact on properties that 
are measured using the OPI 2.0 system. Our primary goal in 
developing new and refined metrics was their use as tools to 
identify and characterize patient subpopulations, particularly 
in multifactorial diseases such as dry eye. As the next step 
in the validation of OPI 2.0 System-based measures, we 
examined dry eye subjects before, immediately after, and 
30 minutes after a 90-minute CAE challenge.
Methods
Inclusion criteria
Subjects were recruited from an existing database of dry 
eye patients, and a total of 33 subjects were enrolled. Criteria 
for inclusion in the database included a history of dry eye, 
use of artificial tears, and a Schirmer’s test score4 of ,5 mm 
in at least one eye. Enrolled subjects were at least 18 years of 
age, had a history of use, or desire to use an eye drop for dry 
eye symptoms within the past 6 months, and had a best cor-
rected visual acuity of +0.7 or better in both eyes, as assessed 
by the Early Treatment of Diabetic Retinopathy Study scale. 
Subjects also had to satisfy each of the following criteria at 
baseline: a forced stare TFBUT score of ,5 seconds in at 
least one eye; a deficient OPI (,1) during at least 30% of 
interblink intervals, as determined by a trained technician; 
and a total corneal fluorescein staining score of $3, based 
on the sum of the central, superior, and inferior regions of 
the cornea, as defined by the Ora scale (see below).
Exclusion criteria
Subjects were excluded from the study if they had clini-
cally significant anterior blepharitis in the opinion of the 
 investigator; were diagnosed with ongoing ocular infection 
(bacterial, viral, or fungal), or active ocular inflammation (eg, 
follicular conjunctivitis); wore contact lenses in the  previous 
week; had used any eye drop in the 4 hours prior to the 
study; had previously undergone laser in situ keratomileusis 
surgery, or any other ocular surgery in the past year; were 
currently taking any topical ophthalmic prescription, or over-
the-counter solutions, artificial tears, gels or scrubs that could 
not be discontinued for the duration of the trial; had used 
Restasis® in the previous 30 days; had a systemic disease, 
or uncontrolled medical condition that could interfere with 
study measurements or subject compliance; were currently 
pregnant or nursing; or had received an experimental drug 
or device within 30 days prior to the visit.
Study design
This was a single-center study, conducted in a single visit 
that included a 90-minute session in the CAE. Written 
informed consent was obtained prior to study procedures. 
Patient-reported and investigator-observed adverse events 
were captured and monitored for the duration of the study. 
A summary of the protocol, including the tests which were 
conducted, is shown in Table 1. The primary endpoint for 
this study was MBA prior to CAE exposure compared with 
MBA immediately and 30 minutes post-CAE exposure. 
Secondary endpoints included fluorescein staining, TFBUT, 
and redness prior to CAE compared with fluorescein  staining, 
TFBUT, and redness immediately- and 30 minutes post- 
CAE exposure. The scoring of corneal staining was based 
on a 5-point Ora scale (0–4) where 0 = no staining and 
4 =  confluent fluorescein staining across the entire cornea. 
Redness was scored using a 5-point Ora scale (0–4), where 
0 = no detectable vasodilation and 4 = broad, prominent 
ciliary and conjunctival vasodilation. Both scales have 
been used previously.15,16 Additional secondary endpoints 
Table 1 Overview of study protocol
Dry eye metrics Pre-CAESM  
(baseline)
90 minute exposure to controlled  
adverse environment (CAESM)
Post-CAESM 30 minutes  
post-CAESM
Video-based assessments
 Break-up area (MBA)    
 Blink rate (inter-blink interval)    
 Palpebral fissure width    
Conjunctival redness    
Tear film break-up time    
Corneal fluorescein staining    
Subject-reported ocular discomfort  
(at 5 minute intervals)
                    
Note: Tests were conducted in the order shown at the three time points.
Abbreviation: MBA, mean break-up area.
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included video-based measurements (including IBI and 
palpebral fissure width), as well as TFBUT, collected at all 
three time points.
Statistical analysis
Thirty-three subjects were enrolled in the study. Of the 66 eyes 
under study, 65 provided readable videos, and data from 
these 65 eyes comprised the complete analysis sample. All 
33 subjects in the intent-to-treat population met the require-
ments of the protocol criteria. We also analyzed subgroups 
that were defined by their baseline MBA measure. The first 
of these were subjects with an initial MBA (MBA
I
) . 0.2, a 
value used to identify those with moderate to severe dry eye. 
This cutoff was based on previously published studies that 
showed subjects who reported dry eye signs and symptoms 
had a mean MBA score of 0.232.5 Demographic variables 
(age, sex, duration of dry eye disease) were summarized by 
means and standard deviations. An additional measure, ocular 
discomfort, was provided by the subjects and was collected 
every 5 minutes during the 90-minute CAE, using a 5-point 
ordinal scale. Subjects scored their discomfort, and these 
measurements were used to calculate average discomfort 
during the CAE, and tearing. We defined tearing as the time 
at which discomfort either reduced or reached a plateau at a 
value less than the maximum, based upon previous studies 
demonstrating that this plateau is associated with a compen-
satory tearing response.17
For those variables with long right-tailed distributions 
(including MBA, OPI2, blink rate, IBI, palpebral fissure, 
and break-up time) we used a gamma multiplicative model 
to obtain estimates for pre-CAE and post-CAE means, ratios 
of means, 95% confidence intervals, and P-values for tests 
of equality. Corneal fluorescein staining and conjunctival 
redness were analyzed using normal linear models. We used 
a generalized estimating equation to accommodate the 
within-subject correlation between eyes for both models. 
For the latter purpose, a sandwich variance was used in 
conjunction with a working independence correlation 
structure. All models were fit using the Genmod module of 
SAS version 9.2 (SAS Institute Inc, Cary, NC).18
For variables measured pre- and post-CAE, bivariate 
relationships were obtained via correlations between change 
scores (eg, post-CAE MBA minus pre-CAE MBA versus 
pre-CAE blink rate minus post-CAE blink rate). These change 
scores were also correlated with variables collected in the CAE 
(average discomfort, and tearing [score = 1 if there was tearing 
within 90 minutes, score = 0 otherwise]), and demographic 
variables of age, duration of dry eye disease, and gender.
Table 2 Study populations: demographics and initial MBA values*
Subjects Age ± SD % male Years with  
dry eye
MBAI
All eyes (n = 65) 64.1 ± 10.8 34 13.4 ± 12.4 0.55 ± 0.85
MBA . 0.5 (n = 19) 61.9 ± 14.4 21 14.5 ± 14.8 1.51 ± 1.05
MBA . 0.2 (n = 35) 64.5 ± 12.2 40 14.2 ± 14.5 0.96 ± 0.98
MBA , 0.5 (n = 46) 64.9 ± 9.0 39 13.0 ± 11.4 0.15 ± 0.14
MBA , 0.2 (n = 30) 63.6 ± 9.0 27 12.4 ± 9.5 0.06 ± 0.06
Note: Expressed as mean values ± SD.
Abbreviations: MBA, mean break-up area; MBAI, initial mean break-up area.
Results
In this single-visit study, we examined the effect of the CAE 
on MBA for subjects with confirmed dry eye disease. A total 
of 33 dry eye subjects completed the study and data from 
65 qualified eyes were entered into the analysis algorithm. 
One video file was corrupted during the course of collection 
and could not be included in the analysis. No treatment was 
administered in the course of the study.
The demographics of the study populations were gener-
ally representative of the larger population of all dry eye 
patients.1 The study population was 34% male, had a mean 
age of 64 years, and had experienced dry eye disease for an 
average of 13.4 years; a similar demographic profile also 
described all of the subpopulations analyzed in this study, 
as summarized in Table 2.
The primary endpoint was the change in MBA measured 
at baseline, immediately following CAE, and 30 minutes after 
exposure to the CAE, for subjects with MBA
I
 measures of 
0.2 or greater. The change in MBA for three subject popula-
tions (all subjects, MBA
I
 scores , 0.2, MBA
I
 scores . 0.2) 
is shown in Figure 1A. Subjects with higher MBA
I
 are 
those with more severe dry eye,7 and we found that in this 
 population, as well as in the entire subject population, 
 exposure to the CAESM caused a significant decrease in MBA. 
This figure also shows that for those subjects with less severe 
dry eye (MBA
I
 , 0.2), there was a trend toward increased 
MBA which was not statistically significant.
Figure 1B and C show comparisons of two additional met-
rics in these three populations: blink rate and corneal staining. 
The change in blink rate that was observed over the course 
of the study is interesting in that while the population as a 
whole increased significantly, the group with MBA
I
 . 0.2 
did not exhibit this increase (Figure 1B and Table 2). Corneal 
fluorescein staining was noteworthy for two reasons. First, 
the difference between those with MBA
I
 . 0.2 and those 
with MBA
I
 , 0.2 was significant (P ,0.001), consistent 
with our premise that those with higher MBA scores have 
more severe dry eye (Table 2). Second, all subjects showed 
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significant increases in staining over the course of the visit, 
as expected for exposure to the CAE (Figure 1C, Table 3). 
Of note, this increase in corneal staining occurred regardless 
of the change in MBA observed for all subjects.
Secondary endpoints included blink rate, palpebral 
fissure size, corneal staining, conjunctival redness, TFBUT, 
and IBI. The mean values for these parameters are shown in 
Table 3; differences and P-values between pre-CAESM and 
post-CAESM values are shown in Table 4.
The major finding was the statistically significant decrease 
in the MBA immediately following CAE exposure. MBA 
values 30 minutes post-CAE were also significantly lower 
than baseline, although there was some recovery between 
the two post-CAE time points. As expected, both fluorescein 
staining and redness increased with CAE exposure (Tables 3 
and 4). Blink rate and palpebral fissure width also decreased 
significantly across the population, at both post-CAESM times. 
In contrast, mean IBI and TFBUT changed only minimally, 
and not significantly. Table 4 summarizes the difference 
scores for all endpoints, and shows the same pattern of sig-
nificance for primary and secondary endpoints seen in mean 
value comparisons.
Based upon the pattern of decreased MBA and increased 
blink rates, we examined a second set of subpopulations 
that were defined using a higher threshold of MBA
I
 (.0.5; 
n = 19). Even at this higher threshold, all subjects who dis-
played a decrease in MBA were included. These subjects 
had a higher initial corneal staining score, and exhibited a 
pronounced decrease in MBA in response to CAE exposure 
(Table 4,  Figure 2A). Analysis of these subpopulations 
(initial MBA . 0.2 or . 0.5) suggests that the MBA metric 
may provide the means to distinguish between individuals 
who respond in the CAESM with differing compensatory 
 mechanisms. Comparison of subjects with either high or low 
MBA showed that there was a clear, statistically significant 
difference in the way these two groups responded to the 
CAESM. Figures 1A and 2A show that the decrease in MBA 
observed in the full study population was entirely due to 
the decrease observed in the subpopulation with the higher 
MBA
I
, and that for the two lower MBA
I
 groups, the mean 
value increased slightly over the course of the CAESM expo-
sure (Table 4). A second distinction between those with low 
versus high initial MBA values is shown in Figures 1B and 
2B; despite a decrease in MBA during the CAESM, subjects 
with high MBA values showed no change in blink rate, while 
those with low initial MBA values increased their blink rate in 
the CAESM by almost 50% (Table 4). Reduction in palpebral 
fissure accompanied this increase in blink rate. While it is 
reasonable to point out that the largest decrease in MBA may 
simply be due to a high MBA
I
, the differences in blink rates 
clearly represent a difference in compensatory responses.
TFBUT has been used as a standard metric in dry eye 
studies for many years, but in this study did not reflect the 
changes in dry eye signs and symptoms resulting from CAESM 
exposure. Figure 2C and Tables 3 and 4, show that none of 
the populations examined in this study showed a significant 
change in TFBUT, despite the fact that other metrics associ-
ated with dry eye, including corneal staining, ocular redness, 
and discomfort (not shown) increased over the time course 
of the CAESM.
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Figure 1 A Comparison of endpoints before and after CAESM exposure.
Notes: Graphs show mean values (±SD) for the three endpoints in the total 
population, as well as for subjects with MBAI . 0.2 (severe dry eye), and MBAI 
, 0.2 (moderate dry eye). (A) Decrease in MBA was limited to subjects with MBAI 
. 0.2. (B) Compensatory increases in blink rates were primarily seen in subjects 
with MBAI ,0.2. (C) All subjects experienced similar increases in corneal staining. 
Abbreviations: CAESM, controlled adverse environment; MBA, mean break-up 
area; MBAI, initial mean break-up area.
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We next did a correlation analysis to test whether specific 
endpoints might show an association with MBA changes; 
these data are summarized in Table 5 for the population as a 
whole, and for the subpopulation of subjects with MBA
I
 . 0.2. 
Of the endpoints analyzed, only tearing and blink rate (and 
the related parameter, IBI) were significantly correlated with 
MBA measures. In addition, all endpoints except IBI showed 
a positive correlation with MBA in the full study population. 
When this same analysis was applied to the high and low MBA 
subpopulations, the correlation between blink rate and MBA 
was restricted to the high MBA population, while subjects 
in the low MBA population exhibited an inverse correlation 
with these two parameters. This distinction indicates that the 
two subpopulations may be responding to the CAESM with 
different compensatory mechanisms. Collectively our results 
suggest that subjects in the low MBA group respond to the 
effects of the CAESM, at least in part, by increasing their blink 
rate, while the high MBA group does not. Despite this lack of 
change in compensatory metrics, subjects in the high MBA 
group exhibited a significant decrease in MBA and therefore 
are clearly responding to the CAESM in some way.
Throughout the course of CAESM exposure, subjects were 
asked to rate their ocular discomfort (not shown). The values 
for all groups displayed a slow, consistent increase in scores 
over the time course of the CAESM, but none of the differences 
between group scores were statistically significant at any time 
point (that is, discomfort could not explain the differences 
in responses seen in the two groups).
Discussion
Dry eye disease is an exceedingly complex disease because 
of its variety of etiologies and the overlapping, interacting 
sensory elements and response mechanisms required for an 
optimally-tuned tear film. The identification of endpoints that 
are both meaningful and measurable has been problematic. 
The study presented here represents one step in the process 
of establishing robust quantitative metrics for clinical studies. 
Our goal was to identify measures that would be responsive 
in clinical models designed to replicate the disease process, 
and that could distinguish between the subpopulations that 
are characteristic of this disease. The data presented here 
demonstrated that the OPI 2.0 system and the measure of 
Table 3 CAESM effects on measures of dry eye
MBAa Blink rateb Palpebral 
fissurec
Corneal  
stainingd
Rednessd TFBUTe IBIf
All eyes (n = 65)
Pre-CAESM 0.55 ± 0.85 22.21 ± 10.3 1.34 ± 0.19 1.68 ± 0.53 1.53 ± 0.47 3.77 ± 1.89 3.6 ± 1.8
Post-CAESM 0.26 ± 0.35g 29.01 ± 16.0 1.24 ± 0.18g 2.34 ± 0.45g 2.35 ± 0.56g 3.82 ± 1.56 3.29 ± 2.0
30 min 
post-CAESM
0.31 ± 0.52h 26.15 ± 12.6h 1.28 ± 0.21g 2.46 ± 0.39g 2.22 ± 0.65g 4.09 ± 2.22 3.35 ± 2.2
MBAI . 0.2 (n = 35)
Pre-CAESM 0.96 ± 0.98 20.56 ± 9.1 1.35 ± 0.21 1.85 ± 0.54 1.67 ± 0.48 3.89 ± 1.99 3.82 ± 1.91
Post-CAESM 0.37 ± 0.41g 24.12 ± 12.9 1.25 ± 0.20g 2.37 ± 0.49g 2.47 ± 0.54g 4.05 ± 1.78 3.85 ± 2.23
30 min 
post-CAESM
0.41 ± 0.51g 23.73 ± 10.9 1.33 ± 0.22 2.55 ± 0.40* 2.41 ± 0.60g 4.21 ± 2.47 3.61 ± 2.4
Notes: Mean values ± standard deviation. a% of corneal surface; bblinks/sec; ccentimeters; dOra 0–4 scale; eseconds; f1/seconds; gP,0.001;  hP,0.01 as compared with 
pre-CAE value.
Abbreviations: MBAI, initial mean break-up area; MBA, mean break-up area; TFBUT, tear film break-up time; IBI, interblink interval; CAE
SM, controlled adverse 
environment.
Table 4 Difference values for primary and secondary endpoints in different subpopulations
MBAa Blink rateb Palpebral fissurec Stainingd Rednessd TFBUTe IBIf
All 
n = 65
-0.29 
(P , 0.001)
6.8 
(P , 0.001)
-0.11 
(P , 0.001)
0.52 
(P , 0.001)
0.80 
(P , 0.001)
0.17 
(P = 0.661)
-0.30 
(P = 0.935)
MBAI . 0.2 
(n = 35)
-0.59 
(P , 0.001)
3.56 
(P = 0.088)
-0.10 
(P , 0.001)
0.52 
(P , 0.001)
0.80 
(P , 0.001)
0.17 
(P = 0.661)
0.03 
(P = 0.935)
MBAI , 0.2 
(n = 30)
0.06 
(P = 0.026)
10.58 
(P , 0.001)
-0.11 
(P , 0.001)
0.83 
(P , 0.001)
0.85 
(P , 0.001)
-0. 07 
(P = 0.778)
-0.70 
(P = 0.006)
Notes: Values represent the change from pre- to post-Controlled Adverse Environment measures. a% of corneal surface; bblinks/sec; ccentimeters; dOra 0–4 scale; eseconds; 
f1/seconds. Subpopulations are based upon the initial mean break-up area measure. Shaded areas highlight statistically significant changes in subpopulations.
Abbreviations: MBA, mean break-up area; TFBUT, tear film break-up time; IBI, interblink interval; MBAI, initial mean break-up area.
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Figure 2 Subpopulation comparisons. 
Notes: Graphs show mean values (±SD) pre, immediately post and 30 min post 
CAESM for two alternative subpopulations of subjects with MBAI . 0.5 (n = 19) and 
MBAI , 0.5 (n = 46). (A) and (B) show that the decrease in MBA in the “severe” 
subpopulation was primarily seen in subjects with the highest MBAI (.0.5) who did 
not respond to the CAE with increased blink rates (seen in subjects with milder 
dry eye). Panel (C) shows that forced stare TFBUT was not altered in the total 
population, nor in these subgroups. 
Abbreviations: MBA, mean break-up area; MBAI, initial mean break-up area; 
CAESM, controlled adverse environment; TFBUT, tear film break-up time.
Table 5 Pearson correlation coefficients between MBA and secondary endpoint measures
Tearing Blink rate Fissure Staining Redness TFBUT IBI
MBAI . 0.2 
(n = 35)
0.336 
(P = 0.048)
0.399 
(P = 0.0174)
0.203 
(P = 0.242)
-0.194 
(P = 0.234)
0.263 
(P = 0.127)
-0.162 
(P = 0.353)
-0.344 
(P = 0.043)
All subjects 
(n = 65)
0.177 
(P = 0.159)
0.338 
(P = 0.0059)
0.141 
(P = 0.260)
0.0169 
(P = 0.894)
0.183 
(P = 0.145)
-0.151 
(P = 0.230)
-0.341 
(P = 0.005)
Note: Significant values (P,0.05) are shaded.
Abbreviations: MBA, mean break-up area; TFBUT, tear film break-up time; IBI, interblink interval; MBAI, initial mean break-up area.
MBA can provide the assessment tools necessary to meet 
this goal.
The key finding of this study was that the metric of MBA 
was shown to identify subpopulations of dry eye subjects 
who displayed distinct compensatory mechanisms when 
challenged with an adverse environment. In contrast, the 
traditional metric of tear film stability, TFBUT, was not sig-
nificantly altered by CAESM exposure. Patients also exhibited 
significant increases in corneal staining, ocular redness, and 
decreases in palpebral fissure width, which are all characteris-
tic of dry eye disease. Thus, in a clinical model which reliably 
elicits signs and symptoms of dry eye disease, MBA provided 
a useful new metric that was superior to TFBUT.
Patients completing the CAESM exposure fell into two 
groups. The first group, which comprised about 70% of all 
subjects, was distinguished by a relatively stable MBA that 
was maintained in part, by an increase in blink rate and a 
decrease in palpebral fissure width. These changes indicated 
they were able to respond to the environmental challenge with 
these (and perhaps other) mechanisms in order to maintain 
a relatively constant corneal surface exposure, as measured 
by MBA. The remaining 30% of subjects began the study 
with levels of corneal staining similar to the low MBA group 
despite a baseline MBA that was 10-fold higher. Subjects 
in this group responded to the CAE by lowering their MBA 
more than 3-fold during the course of the CAE exposure. 
While we speculate that this response employed some com-
bination of increased tearing, mucin secretion, or meibum 
expression, our study did not examine these specific tear 
film parameters. The net effect of their response however 
was evidenced by the fact that corneal staining between the 
two groups was comparable. Future studies will benefit from 
inclusion of techniques that can monitor changes in these tear 
film components during the course of CAE exposure.
Our study has direct impact on the design of therapeutic 
development strategies going forward. First, we provided 
direct evidence that break-up area, and not break-up time, 
is the more valuable parameter in studies of induced dry 
eye disease. Second, we established that the metrics of the 
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OPI 2.0 system can distinguish subpopulations of subjects 
who are likely to require different therapeutic strategies for 
successful amelioration of their dry eye signs and symptoms. 
An important next step in the refinement of the OPI 2.0 sys-
tem will be to associate the subgroups identified using metrics 
such as MBA, with clinically relevant patient populations.
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